newswire

Senzo Secures Additional $1.9MM Equity Funding for Its PCR-Accurate Lateral Flow Test

The funding, led by existing investors BioAdvance and Wellness Coaches, follows additional 3rd party studies by University College London and LateralDx, confirming that Senzo's Amplified Lateral Flow ...
News Medical

Review on lateral flow test use spearheaded by SARS-CoV-2 pandemic

In a recent review published in Nature Reviews Bioengineering, researchers assessed the changing landscape of lateral flow tests (LFTs), and the development of next-generation LFTs based on lessons ...
newswire

Senzo Receives Funding From the Biomedical Advanced Research and Development Authority (BARDA) to Advance Its PCR-Accurate Lateral Flow COVID-19 Test

Senzo, a global life sciences company developing high-accuracy, low-cost, point-of-care diagnostic technologies, today announced a partnership with BARDA, part of the Administration for Strategic ...
BIOENGINEER

Point-of-care infectious disease testing advances, with evidence gaps

A 2026 narrative review finds that rapid point-of-care technologies can detect pathogens and resistance markers closer to ...
News Medical

Revolutionising point-of-care molecular diagnostics with a sub 10 minute PCR test

Polymerase chain reaction (PCR) tests are one of the most popular diagnostic tools for the detection and diagnosis of viral diseases, such as coronavirus (COVID-19), due to their ability to rapidly ...